Market Summary
USD345.29+6.66
Market Closed1.97%
COO Stock Price
COO RSI Chart
COO Valuation
COO Price/Sales (Trailing)
COO Profitability
COO Fundamentals
COO Revenue
COO Earnings
Price Action
52 Week Range
244.22429.84
(Low)(High)
Last 7 days
1.0%
Last 30 days
0.1%
Last 90 days
4.5%
Trailing 12 Months
-13.3%
COO Financial Health
COO Investor Care
Peers (Alternatives to Cooper Companies)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
DHR | 181.6B | 31.5B | -6.84% | -10.46% | 25.19 | 5.77 | 6.85% | 12.06% |
MDT | 105.5B | 30.8B | -7.09% | -24.59% | 25.94 | 3.43 | -3.19% | -17.38% |
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
COO | 17.1B | - | 0.07% | -13.27% | 45.46 | 5.16 | 13.20% | -60.04% |
| MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
STAA | 3.0B | 284.4M | -11.77% | 2.91% | 77.1 | 10.51 | 23.40% | 58.18% |
| SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
BLFS | 853.3M | 154.8M | -6.04% | 0.61% | -8.2 | 5.51 | 60.29% | -2309.58% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Financials for Cooper Companies
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Revenue | -100.0% | 3,308 | 3,212 | 3,115 | 3,019 | |
| Gross Profit | 1.9% | 2,180 | 2,140 | 2,105 | 2,069 | 2,024 |
| S&GA Expenses | 0.9% | 1,354 | 1,342 | 1,296 | 1,306 | 1,269 |
| R&D Expenses | 4.9% | 116 | 110 | 107 | 103 | 98.00 |
| EBITDA | 3.7% | 552 | 533 | 907 | 715 | - |
| EBITDA Margin | 3.7% | 0.17* | 0.16* | 0.28* | 0.24* | - |
| Earnings Before Taxes | 0.0% | 476 | 475 | 525 | 501 | 474 |
| EBT Margin | 0.0% | 0.14* | 0.14* | 0.16* | 0.17* | - |
| Interest Expenses | 34.0% | 77.00 | 57.00 | 40.00 | 28.00 | 23.00 |
| Net Income | -2.7% | 375 | 386 | 431 | 948 | 939 |
| Net Income Margin | -2.7% | 0.11* | 0.12* | 0.13* | 0.32* | - |
| Free Cahsflow | -5.6% | 425 | 450 | 524 | 487 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Assets | 0.6% | 11,561 | 11,492 | 11,552 | 11,778 | 11,663 |
| Current Assets | 2.9% | 1,578 | 1,534 | 1,598 | 1,738 | 1,698 |
| Cash Equivalents | -14.3% | 119 | 138 | 246 | 399 | 281 |
| Inventory | 4.8% | 659 | 629 | 622 | 604 | 588 |
| Net PPE | -0.3% | 1,361 | 1,366 | 1,362 | - | - |
| Goodwill | 1.7% | 3,672 | 3,610 | 3,666 | 3,719 | 3,836 |
| Liabilities | -2.1% | 4,225 | 4,318 | 4,469 | 4,764 | 4,736 |
| Current Liabilities | -28.5% | 916 | 1,280 | 1,376 | 1,648 | 1,664 |
| . Short Term Borrowings | -41.0% | 535 | 906 | 912 | - | - |
| Long Term Debt | 11.8% | 2,627 | 2,351 | - | - | - |
| LT Debt, Non Current | 0.0% | 2,347 | 2,347 | 2,347 | - | - |
| Shareholder's Equity | 2.2% | 7,336 | 7,175 | 7,083 | 7,014 | 6,926 |
| Retained Earnings | 1.3% | 6,668 | 6,585 | 6,519 | 6,423 | 6,296 |
| Additional Paid-In Capital | 0.8% | 1,779 | 1,766 | 1,751 | 1,737 | 1,719 |
| Accumulated Depreciation | 2.3% | 1,385 | 1,354 | 1,334 | - | - |
| Shares Outstanding | 0.2% | 49.00 | 49.00 | 49.00 | 49.00 | 49.00 |
| Minority Interest | 0% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
| Cashflow From Operations | 0.1% | 693 | 692 | 736 | 696 | 757 |
| Share Based Compensation | - | 54.00 | - | - | - | - |
| Cashflow From Investing | 85.0% | -275 | -1,831 | -1,797 | -1,858 | -1,983 |
| Cashflow From Financing | -148.4% | -577 | 1,194 | 1,204 | 1,464 | 1,396 |
| Dividend Payments | 0% | 3.00 | 3.00 | 6.00 | - | - |
| Buy Backs | -100.0% | 0.00 | 79.00 | 79.00 | 79.00 | 79.00 |
Risks for COO
What is the probability of a big loss on COO?
37.3%
Probability that Cooper Companies stock will be more than 20% underwater in next one year
15.4%
Probability that Cooper Companies stock will be more than 30% underwater in next one year.
8.8%
Probability that Cooper Companies stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does COO drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Cooper Companies was unfortunately bought at previous high price.
Drawdowns
Returns for COO
Cumulative Returns on COO
12.6%
10-Year Cumulative Returns
12.8%
7-Year Cumulative Returns
7.5%
5-Year Cumulative Returns
5.2%
3-Year Cumulative Returns
What are the long-term rolling returns for COO?
FIve years rolling returns for Cooper Companies.
Annualized Returns
Which funds bought or sold COO recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | new | - | 221,236 | 221,236 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 17.06 | 126,145,000 | 396,372,000 | 0.43% |
2023-03-10 | BAILLIE GIFFORD & CO | reduced | -4.66 | 1,611,340 | 9,890,340 | 0.01% |
2023-03-08 | Capital Asset Advisory Services LLC | reduced | -58.86 | -194,410 | 258,590 | 0.02% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 0.78 | 143,000 | 685,000 | -% |
2023-02-28 | Voya Investment Management LLC | added | 5.04 | -30,040,800 | 72,984,200 | 0.10% |
2023-02-24 | National Pension Service | added | 1.16 | 5,164,390 | 26,538,600 | 0.05% |
2023-02-24 | NATIXIS | added | 107 | 1,354,240 | 2,205,240 | 0.01% |
2023-02-24 | SRS Capital Advisors, Inc. | added | 27.54 | 11,099 | 29,099 | -% |
2023-02-22 | CVA Family Office, LLC | added | 66.67 | 4,267 | 8,267 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Cooper Companies News
Schedule 13G FIlings of Cooper Companies
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | price t rowe associates inc /md/ | 0.4% | 205,908 | SC 13G/A | |
| Feb 14, 2023 | t. rowe price investment management, inc. | 5.0% | 2,473,414 | SC 13G | |
| Feb 09, 2023 | vanguard group inc | 11.31% | 5,583,124 | SC 13G/A | |
| Feb 07, 2023 | blackrock inc. | 7.7% | 3,808,360 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 6.3% | 3,159,263 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 10.72% | 5,298,087 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 8.1% | 4,000,869 | SC 13G/A | |
| Feb 16, 2021 | generation investment management llp | 3.1% | 1,528,921 | SC 13G/A | |
| Feb 16, 2021 | price t rowe associates inc /md/ | 8.0% | 3,949,277 | SC 13G/A | |
| Feb 11, 2021 | janus henderson group plc | 4.4% | 2,155,648 | SC 13G/A |
COO Fair Value
Cooper Companies fair value in different scenarios
The table shows the Fair Value estimates for Cooper Companies for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 259.04 -24.98% | 489.03 41.63% | 645.65 86.99% | 849.35 145.98% | 1040.18 201.25% |
| Current Inflation | 245.01 -29.04% | 441.84 27.96% | 571.77 65.59% | 741.02 114.61% | 899.24 160.43% |
| Very High Inflation | 227.10 -34.23% | 385.24 11.57% | 485.30 40.55% | 616.31 78.49% | 738.52 113.88% |
Historical Cooper Companies Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Cooper Companies
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 16, 2023 | 8-K | Current Report | |
| Mar 15, 2023 | 4 | Insider Trading | |
| Mar 09, 2023 | 4 | Insider Trading | |
| Mar 07, 2023 | 4 | Insider Trading | |
| Mar 03, 2023 | 10-Q | Quarterly Report | |
| Mar 02, 2023 | 8-K | Current Report | |
| Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 14, 2023 | SC 13G | Major Ownership Report | |
| Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
| Feb 07, 2023 | SC 13G/A | Major Ownership Report |
Latest Insider Trading transactions for COO
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-15 | PETERSMEYER GARY S | sold | -235,044 | 335 | -700 | - |
2023-03-09 | Warner Gerard H III | sold | -414,087 | 340 | -1,216 | president, coopervision, inc. |
2023-03-09 | PETERSMEYER GARY S | gifted | - | - | -75.00 | - |
2023-03-09 | PETERSMEYER GARY S | gifted | - | - | 75.00 | - |
2023-03-07 | WEISS ROBERT S | sold | -12,667,900 | 337 | -37,510 | - |
2023-03-07 | WEISS ROBERT S | acquired | 4,936,320 | 131 | 37,510 | - |
2023-01-08 | Sheffield Holly R | acquired | - | - | 589 | president, csi |
2023-01-08 | Warner Gerard H III | sold (taxes) | -443,198 | 345 | -1,284 | president, coopervision, inc. |
2023-01-08 | Ricupati Agostino | sold (taxes) | -92,505 | 345 | -268 | svp & cao |
2023-01-08 | Andrews Brian G | sold (taxes) | -22,090 | 345 | -64.00 | evp, cfo & treasurer |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
COO Income Statement
2023-01-31Consolidated Condensed Statements of Income and Comprehensive Income - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
|---|---|---|
Jan. 31, 2023 | Jan. 31, 2022 | |
| Income Statement [Abstract] | ||
| Net sales | $ 858.5 | $ 787.2 |
| Cost of sales | 300.0 | 268.8 |
| Gross profit | 558.5 | 518.4 |
| Selling, general and administrative expense | 330.9 | 319.1 |
| Research and development expense | 31.6 | 26.2 |
| Amortization of intangibles | 46.5 | 42.3 |
| Operating income | 149.5 | 130.8 |
| Interest expense | 26.1 | 6.6 |
| Other expense, net | 1.3 | 2.3 |
| Income before income taxes | 122.1 | 121.9 |
| Provision for income taxes (Note 6) | 37.5 | 26.6 |
| Net income | $ 84.6 | $ 95.3 |
| Earnings per share (Note 7): | ||
| Basic (in dollars per share) | $ 1.71 | $ 1.93 |
| Diluted (in dollars per share) | $ 1.70 | $ 1.91 |
| Number of shares used to compute earnings per share: | ||
| Basic (in shares) | 49.4 | 49.4 |
| Diluted (in shares) | 49.7 | 49.9 |
| Other comprehensive income, net of tax: | ||
| Cash flow hedges | $ (21.0) | $ 13.3 |
| Foreign currency translation adjustment | 84.0 | (49.2) |
| Comprehensive income | $ 147.6 | $ 59.4 |
COO Balance Sheet
2023-01-31Consolidated Condensed Balance Sheets - USD ($) $ in Millions | Jan. 31, 2023 | Oct. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 118.2 | $ 138.2 |
| Trade accounts receivable, net of allowance for credit losses of $24.7 at January 31, 2023, and $20.7 at October 31, 2022 | 581.8 | 557.8 |
| Inventories (Note 3) | 659.1 | 628.7 |
| Prepaid expense and other current assets | 218.4 | 208.9 |
| Total current assets | 1,577.5 | 1,533.6 |
| Net property, plant and equipment | 1,464.0 | 1,432.9 |
| Goodwill | 3,672.3 | 3,609.7 |
| Other intangibles, net (Note 4) | 1,863.4 | 1,885.1 |
| Deferred tax assets | 2,415.1 | 2,443.1 |
| Other assets | 568.8 | 587.9 |
| Total assets | 11,561.1 | 11,492.3 |
| Current liabilities: | ||
| Short-term debt (Note 5) | 68.1 | 412.6 |
| Accounts payable | 224.1 | 248.8 |
| Employee compensation and benefits | 167.2 | 152.1 |
| Deferred revenue | 106.4 | 93.6 |
| Other current liabilities | 350.0 | 373.1 |
| Total current liabilities | 915.8 | 1,280.2 |
| Long-term debt (Note 5) | 2,627.3 | 2,350.8 |
| Deferred tax liabilities | 144.3 | 149.9 |
| Long-term tax payable | 112.4 | 113.2 |
| Deferred revenue | 195.1 | 198.3 |
| Accrued pension liability and other | 230.5 | 225.2 |
| Total liabilities | 4,225.4 | 4,317.6 |
| Contingencies (Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock, $10 cents par value, 1.0 shares authorized, zero shares issued or outstanding | 0.0 | 0.0 |
| Common stock, $10 cents par value, 120.0 shares authorized, 53.9 issued and 49.4 outstanding at January 31, 2023, and 53.8 issued and 49.3 outstanding at October 31, 2022 | 5.4 | 5.4 |
| Additional paid-in capital | 1,779.2 | 1,765.5 |
| Accumulated other comprehensive loss | (403.8) | (466.8) |
| Retained earnings | 6,668.0 | 6,584.9 |
| Treasury stock at cost: 4.5 shares at January 31, 2023, and 4.5 shares at October 31, 2022 | (713.3) | (714.5) |
| Total Cooper stockholders’ equity | 7,335.5 | 7,174.5 |
| Noncontrolling interests | 0.2 | 0.2 |
| Stockholders’ equity (Note 9) | 7,335.7 | 7,174.7 |
| Total liabilities and stockholders’ equity | $ 11,561.1 | $ 11,492.3 |